Oncocyte Corporation (OCX) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
15 CUSHING IRVINE, CA 92618 |
| State of Incorp. | CA |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 9,432 | 20,426 | 36,509 | 7,818 | 22,451 | 8,462 | |||
| Cash and cash equivalents | 9,432 | 19,993 | 35,605 | 7,143 | 22,072 | 8,034 | |||
| Short-term investments | 433 | 904 | 675 | 379 | 428 | ||||
| Receivables | 484 | 2,012 | 1,437 | 203 | |||||
| Prepaid expense | 243 | 264 | 80 | ||||||
| Disposal group, including discontinued operation | 2,121 | ||||||||
| Asset, held-for-sale, not part of disposal group | 139 | ||||||||
| Other current assets | 85 | 295 | 36 | ||||||
| Other undisclosed current assets | 643 | 977 | 869 | 646 | 389 | 180 | |||
| Total current assets: | 10,698 | 25,536 | 39,143 | 9,226 | 22,956 | 8,642 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 1,637 | 2,088 | 2,779 | 343 | ✕ | ||||
| Property, plant and equipment | 4,437 | 3,728 | 614 | ||||||
| Long-term investments and receivables | 13,417 | 10,964 | |||||||
| Long-term investments | 13,417 | 10,964 | |||||||
| Intangible assets, net (including goodwill) | 56,595 | 61,633 | 109,929 | 24,196 | |||||
| Goodwill | 18,684 | 9,187 | |||||||
| Intangible assets, net (excluding goodwill) | 56,595 | 61,633 | 91,245 | 15,009 | |||||
| Prepaid expense | 118 | 268 | |||||||
| Restricted cash and investments | 1,700 | 1,700 | 1,700 | ||||||
| Other noncurrent assets | 463 | 371 | 264 | 88 | 93 | ||||
| Other undisclosed noncurrent assets | 3,799 | 8,763 | 5,748 | 3,594 | 1,850 | 262 | |||
| Total noncurrent assets: | 64,194 | 74,555 | 120,420 | 46,193 | 16,903 | 876 | |||
| TOTAL ASSETS: | 74,892 | 100,091 | 159,563 | 55,419 | 39,859 | 9,518 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2,602 | 3,024 | 5,823 | 3,988 | 1,756 | 1,469 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | 3,556 | 1,287 | 1,303 | |||
| Accounts payable | 953 | 1,253 | 2,447 | 432 | 469 | 166 | |||
| Accrued liabilities | 1,649 | 1,771 | 3,376 | ||||||
| Debt | 1,313 | 2,541 | 1,196 | 1,185 | |||||
| Disposal group, including discontinued operation | 45 | 2,005 | |||||||
| Business combination, contingent consideration, liability | 109 | 1,388 | |||||||
| Due to related parties | ✕ | ✕ | 6 | 2,101 | |||||
| Other undisclosed current liabilities | 4,547 | 6,968 | 5,596 | 2,467 | 1,482 | 806 | |||
| Total current liabilities: | 7,194 | 12,106 | 14,120 | 8,996 | 4,440 | 5,561 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,729 | 1,963 | 534 | ||||||
| Long-term debt, excluding current maturities | 1,508 | 1,905 | 347 | ||||||
| Capital lease obligations | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 187 | ||
| Finance lease, liability | 221 | 58 | ✕ | ||||||
| Liabilities, other than long-term debt | 39,900 | 45,662 | 76,681 | 7,120 | |||||
| Business combination, contingent consideration, liability | 39,900 | 45,662 | 76,681 | 7,120 | |||||
| Other undisclosed noncurrent liabilities | 2,204 | 2,729 | 3,545 | 4,091 | 2,618 | ||||
| Total noncurrent liabilities: | 42,104 | 48,391 | 80,226 | 12,940 | 4,581 | 534 | |||
| Total liabilities: | 49,298 | 60,497 | 94,346 | 21,936 | 9,021 | 6,095 | |||
| Temporary equity, carrying amount | 5,126 | 5,302 | |||||||
| Equity | |||||||||
| Equity, attributable to parent | 20,468 | 34,292 | 65,217 | 33,483 | 30,838 | 3,423 | |||
| Common stock | 310,295 | 294,929 | 252,954 | 157,160 | 124,583 | 74,742 | |||
| Accumulated other comprehensive income | 49 | 39 | 37 | ||||||
| Accumulated deficit | (289,876) | (260,676) | (187,774) | (123,677) | (93,745) | (71,319) | |||
| Total equity: | 20,468 | 34,292 | 65,217 | 33,483 | 30,838 | 3,423 | |||
| TOTAL LIABILITIES AND EQUITY: | 74,892 | 100,091 | 159,563 | 55,419 | 39,859 | 9,518 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,503 | 958 | 7,727 | 1,216 | 96 | |||
| Sublease income | 64 | ✕ | ||||||
| Net investment income | 96 | |||||||
| Cost of revenue | (1,002) | (880) | (4,185) | (1,855) | ||||
| Other undisclosed gross profit | (88) | (96) | (3,354) | |||||
| Gross profit: | 413 | (18) | 188 | (639) | 96 | |||
| Operating expenses | (25,549) | (17,979) | (74,400) | (33,082) | (22,239) | (15,202) | ||
| Other undisclosed operating income (loss) | 4,010 | (96) | ||||||
| Operating loss: | (25,136) | (17,997) | (74,212) | (29,711) | (22,239) | (15,202) | ||
| Nonoperating income (expense) | 281 | (615) | 854 | (1,475) | (187) | (552) | ||
| Other nonoperating income (expense) | 394 | (67) | (37) | 27 | (3) | 91 | ||
| Interest and debt expense | 1,141 | (102) | (59) | (77) | ||||
| Loss from continuing operations before equity method investments, income taxes: | (24,855) | (18,612) | (72,217) | (31,288) | (22,485) | (15,831) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (1,141) | 102 | ||||||
| Loss from continuing operations before income taxes: | (24,855) | (18,612) | (73,358) | (31,186) | (22,485) | (15,831) | ||
| Income tax benefit | 9,261 | 1,254 | ||||||
| Loss from continuing operations: | (24,855) | (18,612) | (64,097) | (29,932) | (22,485) | (15,831) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (64,097) | (29,932) | (22,485) | (15,831) | |
| Loss from discontinued operations | (2,926) | (54,290) | ||||||
| Net loss: | (27,781) | (72,902) | (64,097) | (29,932) | (22,485) | (15,831) | ||
| Other undisclosed net income attributable to parent | 59 | 77 | ||||||
| Net loss attributable to parent: | (27,781) | (72,902) | (64,097) | (29,932) | (22,426) | (15,754) | ||
| Preferred stock dividends and other adjustments | (520) | |||||||
| Other undisclosed net income (loss) available to common stockholders, basic | (942) | |||||||
| Net loss available to common stockholders, basic: | (28,723) | (73,422) | (64,097) | (29,932) | (22,426) | (15,754) | ||
| Dilutive securities, effect on basic earnings per share | 33,941 | |||||||
| Net loss available to common stockholders, diluted: | (28,723) | (39,481) | (64,097) | (29,932) | (22,426) | (15,754) | ||
Comprehensive Income ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (27,781) | (72,902) | (64,097) | (29,932) | (22,485) | (15,831) | ||
| Comprehensive loss: | (27,781) | (72,902) | (64,097) | (29,932) | (22,485) | (15,831) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 10 | 2 | 37 | 59 | 77 | |||
| Comprehensive loss, net of tax, attributable to parent: | (27,771) | (72,900) | (64,060) | (29,932) | (22,426) | (15,754) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.